Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001939167-26-000002

Options or other derivatives

  • Chief People Officer acquired 230,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Costa Carlos Chief People Officer 2026-01-30 Grant or award · Stock option (right to buy) +230,000 $5.71 $1,313,300 230,000 D
Loading xslF345X05/primarydocument.xml…